THE IMPACT OF TYPE 2 DIABETES MELLITUS ON POSTOPERATIVE PAIN INTENSITY FOLLOWING PHACOEMULSIFICATION SURGERY: A STUDY AT SILOAM HOSPITAL BEKASI SEPANJANG JAYA
Keywords:
Diabetes Mellitus type 2, Pain, Cataract, Phacoemulsification surgeryAbstract
Objective : This study aimed to examine the relationship between type 2 diabetes mellitus and postoperative pain intensity among patients undergoing phacoemulsification cataract surgery.
Methods : An analytical observational study was conducted using a cross-sectional design. The population comprised all patients in the post-anesthesia care unit who had undergone phacoemulsification surgery at Siloam Hospital Bekasi Sepanjang Jaya. A total of 52 patients were included using total sampling. Data were collected using a validated pain intensity scale, and the presence of type 2 diabetes mellitus was recorded from medical histories. Statistical analysis was conducted to assess the association between diabetes status and reported pain intensity.
Results : The findings showed that the majority of respondents (48.2%) reported mild postoperative pain. A substantial proportion of participants (80.8%) had a documented diagnosis of type 2 diabetes mellitus. Statistical analysis revealed a significant association between the presence of type 2 diabetes mellitus and higher levels of reported postoperative pain intensity (p = 0.001), indicating that diabetic patients were more likely to experience moderate to severe pain following phacoemulsification compared to non-diabetic patients.
Conclusion : This study concludes that type 2 diabetes mellitus has a significant influence on postoperative pain intensity among phacoemulsification patients. These results suggest the need for more targeted pain management strategies for diabetic patients following ocular surgery, considering their increased vulnerability to higher pain perception during recovery.
Additional Files
Published
Issue
Section
License
Copyright (c) 2025 Journal of Healthcare Technology ISSN XXXX-XXXX

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.